Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial-Reference-Cited by-同舟云学术

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

Published:2013-06 Issue:6 Volume:57 Page:2143-2154
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sulkowski Mark S.,Asselah Tarik,Lalezari Jacob,Ferenci Peter,Fainboim Hugo,Leggett Barbara,Bessone Fernando,Mauss Stefan,Heo Jeong,Datsenko Yakov,Stern Jerry O.,Kukolj George,Scherer Joseph,Nehmiz Gerhard,Steinmann Gerhard G.,Böcher Wulf O.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26276/fullpdf

Reference20 articles.

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989

2. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus;Lamarre;Nature,2003

3. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

4. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N Engl J Med,2011

5. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Photosensitivity Diseases;Rook's Textbook of Dermatology;2024-03-19

2. Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects;PHARMAZIE;2021

3. Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review;Frontiers in Pharmacology;2020-12-14

4. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials;Journal of Clinical and Experimental Hepatology;2019-07

5. The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration;Applied Health Economics and Health Policy;2019-04-27